Zhenyu F. Huo

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index.

Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index.

Journal: Alimentary pharmacology & therapeutics

Published: July 07, 2026

Author Correction: Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC.

Author Correction: Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC.

Journal: Nature communications

Published: April 22, 2026

Association of Metabolic Dysfunction-Associated Steatotic Liver Disease Onset Age With Risk of Incident Type 2 Diabetes.

Association of Metabolic Dysfunction-Associated Steatotic Liver Disease Onset Age With Risk of Incident Type 2 Diabetes.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: February 19, 2026

Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low-Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study.

Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low-Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study.

Journal: Journal of the American Heart Association

Published: February 11, 2026

Systemic inflammatory markers as a supplement to nutrition risk screening of ICU patients.

Systemic inflammatory markers as a supplement to nutrition risk screening of ICU patients.

Journal: Asia Pacific journal of clinical nutrition

Published: January 21, 2026

Body Mass Index Subclassification and Future Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver-Related Events.

Body Mass Index Subclassification and Future Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver-Related Events.

Journal: The Journal of nutrition

Published: December 22, 2025

The association between time-weighted cumulative life's essential 8 and aortic valve calcification.

The association between time-weighted cumulative life's essential 8 and aortic valve calcification.

Journal: Frontiers in cardiovascular medicine

Published: December 08, 2025

Unraveling the potential of targeting methionine metabolism in cancer.

Unraveling the potential of targeting methionine metabolism in cancer.

Journal: Cancer letters

Published: November 17, 2025

Adherence to the EAT-Lancet reference diet and risk of type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and their co-occurrence.

Adherence to the EAT-Lancet reference diet and risk of type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and their co-occurrence.

Journal: Food & function

Published: August 12, 2025

Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts.

Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts.

Journal: Gut

Published: June 13, 2025

Targeting the ATM-TGS1-BRCA1 Axis Overcomes Genotoxic Therapy Resistance in Pancreatic Adenocarcinoma.

Targeting the ATM-TGS1-BRCA1 Axis Overcomes Genotoxic Therapy Resistance in Pancreatic Adenocarcinoma.

Journal: Cancer research

Published: March 31, 2025

Adding salt to foods and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases.

Adding salt to foods and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases.

Journal: European journal of nutrition

Published: March 20, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026